PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550568
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550568
Global cannabidiol market is estimated to be valued at USD 8.12 Bn in 2024 and is expected to reach USD 23.41 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.3% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 8.12 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 16.30% | 2031 Value Projection: | US$ 23.41 Bn |
Cannabidiol or CBD is one of the primary cannabinoids found in cannabis plants like hemp and marijuana. It has several potential medical benefits and therapeutic effects without the psychotropic effects of THC, Delta-9-tetrahydrocannabinol. Rising awareness about the therapeutic properties of CBD for conditions like insomnia, chronic pain, anxiety, and epilepsy can boost adoption of cannabidiol-infused products. Moreover, legalization of cannabis in several countries for medical use offer new opportunities for cannabidiol manufacturers and vendors. Various studies examining the efficacy and safety of CBD are underway, which can further augment the commercialization scope of CBD products in the future.
Rising legalization of medical cannabis and growing adoption of cannabis-based products can drive the global cannabidiol market growth. Increasing investments by companies in cannabis research and new product launches can drive the market growth. Furthermore, rising prevalence of lifestyle diseases, mental health disorders, and chronic conditions boosts demand for therapeutic CBD products. However, certain regulations can hamper the market growth. Lack of clinical trials data on efficacy and safety can also hamper the market growth. Meanwhile, growing adoption in food & beverages, and personal care products can offer opportunities for market expansion.
This report provides in-depth analysis of the global cannabidiol market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cannabidiol market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CV Sciences, Inc., Isodiol, Medical Marijuana Inc., Aurora Cannabis, ENDOCA, Elixinol and GAIA Botanicals LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cannabidiol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabidiol market
Detailed Segmentation-